Response to: ‘Correspondence on ‘Antiinflammatory therapy for COVID-19 infection: the case for colchicine’’ by Perricone et al.

Autor: Shah, Binita, Reyes, Aaron Z., Hu, Kelly A., Teperman, Jacob, Wampler Muskardin, Theresa L., Tardif, Jean-Claude, Pillinger, Michael H.

Publikováno v: Annals of the Rheumatic Diseases; Apr2023, Vol. 82 Issue 4, p1-1, 1p

Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al .

Autor: Shah B; Cardiology, New York University Grossman School of Medicine, New York, New York, USA.; Cardiology, VA New York Harbor Healthcare System, New York, New York, USA., Reyes AZ; Medicine, New York University Grossman School of Medicinee, New York, New York, USA., Hu KA; Medicine, New York University Grossman School of Medicinee, New York, New York, USA., Teperman J; Medicine, New York University Grossman School of Medicinee, New York, New York, USA., Wampler Muskardin TL; Rheumatology, New York University Grosssman School of Medicine, New York, New York, USA., Tardif JC; Research Centre, Montreal Heart Institute, Montreal, Quebec, Canada., Pillinger MH; Rheumatology, New York University Grosssman School of Medicine, New York, New York, USA Michael.Pillinger@nyulangone.org.; Rheumatology, VA New York Harbor Healthcare System, New York, New York, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Apr; Vol. 82 (4), pp. e82. Date of Electronic Publication: 2021 Jan 28.